Finding ways to protect patients from infections and antibiotic resistance
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events
This study is looking for new ways to keep patients in hospitals safer by reducing infections and fighting germs that don't respond to medicine, so if you're admitted to a participating hospital, you might enjoy better care and a healthier environment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11078175 on NIH RePORTER |
What this research studies
This research aims to develop innovative strategies to reduce healthcare-associated infections (HAIs) and combat antimicrobial resistance (AR) that can lead to serious health complications. The project includes several studies focusing on improving environmental disinfection, enhancing antimicrobial stewardship, and refining diagnostic practices. By evaluating new methods such as specialized filters and improved urine culture guidelines, the research seeks to create safer hospital environments and better patient care practices. Patients admitted to participating hospitals may benefit from these advancements in infection prevention and management.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients admitted to hospitals where these innovative infection prevention strategies are being implemented.
Not a fit: Patients who are not hospitalized or those receiving care outside of the participating hospitals may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of infections and antibiotic resistance in healthcare settings, leading to better patient outcomes.
How similar studies have performed: Previous research has shown success in implementing infection control measures and antimicrobial stewardship programs, indicating that this approach has potential for positive outcomes.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Anderson, Deverick John — Duke University
- Study coordinator: Anderson, Deverick John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.